Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karin M Knudson

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Expert Opinion on Biological Therapy|March 12, 2020
Rationale for IL-15 superagonists in cancer immunotherapyKarin M Knudson, James W Hodge, Jeffrey Schlom, et al.
Oncotarget|November 29, 2016
Sublethal exposure to alpha radiation (223Ra dichloride) enhances various carcinomas' sensitivity to lysis by antigen-specific cytotoxic T lymphocytes through calreticulin-mediated immunogenic modulationAnthony S Malamas, Sofia R Gameiro, Karin M Knudson, et al.
Journal for Immunotherapy of Cancer|April 19, 2020
Functional and mechanistic advantage of the use of a bifunctional anti-PD-L1/IL-15 superagonistKarin M Knudson, Kristin C Hicks, Yohei Ozawa, et al.
Journal for Immunotherapy of Cancer|March 23, 2019
Mechanisms involved in IL-15 superagonist enhancement of anti-PD-L1 therapyKarin M Knudson, Kristin C Hicks, Sarah Alter, et al.
European Journal of Immunology|August 22, 2013
The POSH/JIP-1 scaffold network regulates TCR-mediated JNK1 signals and effector function in CD8(+) T cellsCody A Cunningham, Karin M Knudson, Binghao J Peng, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 19, 2013
Cutting edge: The signals for the generation of T cell memory are qualitatively different depending on TCR ligand strengthKarin M Knudson, Sara E Hamilton, Mark A Daniels, et al.
Cell Reports|August 13, 2013
Low-affinity T cells are programmed to maintain normal primary responses but are impaired in their recall to low-affinity ligandsKarin M Knudson, Nicholas P Goplen, Cody A Cunningham, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 15, 2017
NFκB-Pim-1-Eomesodermin axis is critical for maintaining CD8 T-cell memory qualityKarin M Knudson, Curtis J Pritzl, Vikas Saxena, et al.
Oncoimmunology|May 17, 2021
Analysis of the tumor microenvironment and anti-tumor efficacy of subcutaneous vs systemic delivery of the bifunctional agent bintrafusp alfaYohei Ozawa, Kristin C Hicks, Christine M Minnar, et al.
Oncoimmunology|May 4, 2018
M7824, a novel bifunctional anti-PD-L1/TGFβ Trap fusion protein, promotes anti-tumor efficacy as monotherapy and in combination with vaccineKarin M Knudson, Kristin C Hicks, Xiaoling Luo, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Expert Opinion on Biological Therapy|March 12, 2020
Rationale for IL-15 superagonists in cancer immunotherapyKarin M Knudson, James W Hodge, Jeffrey Schlom, et al.
Oncotarget|November 29, 2016
Sublethal exposure to alpha radiation (223Ra dichloride) enhances various carcinomas' sensitivity to lysis by antigen-specific cytotoxic T lymphocytes through calreticulin-mediated immunogenic modulationAnthony S Malamas, Sofia R Gameiro, Karin M Knudson, et al.
Journal for Immunotherapy of Cancer|April 19, 2020
Functional and mechanistic advantage of the use of a bifunctional anti-PD-L1/IL-15 superagonistKarin M Knudson, Kristin C Hicks, Yohei Ozawa, et al.
Journal for Immunotherapy of Cancer|March 23, 2019
Mechanisms involved in IL-15 superagonist enhancement of anti-PD-L1 therapyKarin M Knudson, Kristin C Hicks, Sarah Alter, et al.
European Journal of Immunology|August 22, 2013
The POSH/JIP-1 scaffold network regulates TCR-mediated JNK1 signals and effector function in CD8(+) T cellsCody A Cunningham, Karin M Knudson, Binghao J Peng, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 19, 2013
Cutting edge: The signals for the generation of T cell memory are qualitatively different depending on TCR ligand strengthKarin M Knudson, Sara E Hamilton, Mark A Daniels, et al.
Cell Reports|August 13, 2013
Low-affinity T cells are programmed to maintain normal primary responses but are impaired in their recall to low-affinity ligandsKarin M Knudson, Nicholas P Goplen, Cody A Cunningham, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 15, 2017
NFκB-Pim-1-Eomesodermin axis is critical for maintaining CD8 T-cell memory qualityKarin M Knudson, Curtis J Pritzl, Vikas Saxena, et al.
Oncoimmunology|May 17, 2021
Analysis of the tumor microenvironment and anti-tumor efficacy of subcutaneous vs systemic delivery of the bifunctional agent bintrafusp alfaYohei Ozawa, Kristin C Hicks, Christine M Minnar, et al.
Oncoimmunology|May 4, 2018
M7824, a novel bifunctional anti-PD-L1/TGFβ Trap fusion protein, promotes anti-tumor efficacy as monotherapy and in combination with vaccineKarin M Knudson, Kristin C Hicks, Xiaoling Luo, et al.
Pageof 2